This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment. Serious ...
--Eli Lilly and Company today announced positive topline results from the novel TOGETHER-PsA open-label Phase 3 b trial evaluating the concomitant use of Taltz and Zepbound compared to Taltz alone in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results